The Harsh Goenka group is spending to build a drug-ingredients business, betting that the world’s push to rely less on China will favour Indian makers.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.